Fewer US Men Are Being Screened, Diagnosed, and Treated for Prostate Cancer
In an analysis of approximately 6 million men, PSA testing, prostate biopsy, and prostate cancer detection declined significantly between 2009 and 2014.
Read More
Search Results for: prostate cancer
Novel Biomarker Test Avoids Biopsies by Accurately Predicting High-Grade Prostate Cancer
Studies of the ProteoMediX test showed a high correlation with prostate cancer aggressiveness, and demonstrated that physicians could use the test to avoid performing a large number of biopsies.
Read More
NCCN Guidelines Endorse Biomarker Testing for Prostate Cancer
Updated guidelines include new language supporting the use of Prolaris, from Myriad Genetics, as standard of care in treatment decisionmaking for patients with low-risk and favorable-intermediate-risk prostate cancer.
Read More
Higher Prostate Cancer Risks for Black Men May Warrant New Approach to Screening
A new study indicates that higher prostate cancer death rates among black men in the United States may be due to a higher risk of developing preclinical prostate cancer as well as a higher risk of that cancer progressing more quickly to advanced stages.
Read MoreBlood Test Enables Better Prostate Cancer Detection
The prostate health index test from Beckman Coulter Diagnostics is a simple, multianalyte blood test that helps physicians distinguish prostate cancer from benign prostatic conditions in men aged 50 years or older.
Read More